371 related articles for article (PubMed ID: 27721835)
21. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model.
Cavaglieri RC; Martini D; Sogayar MC; Noronha IL
Transplant Proc; 2009 Apr; 41(3):947-51. PubMed ID: 19376395
[TBL] [Abstract][Full Text] [Related]
23. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
Casiraghi F; Perico N; Cortinovis M; Remuzzi G
Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model.
He J; Wang Y; Sun S; Yu M; Wang C; Pei X; Zhu B; Wu J; Zhao W
Nephrology (Carlton); 2012 Jul; 17(5):493-500. PubMed ID: 22369283
[TBL] [Abstract][Full Text] [Related]
26. Novel insights into MSC-EVs therapy for immune diseases.
Lai P; Weng J; Guo L; Chen X; Du X
Biomark Res; 2019; 7():6. PubMed ID: 30923617
[TBL] [Abstract][Full Text] [Related]
27. Cellular therapy of kidney diseases.
Imai N; Kaur T; Rosenberg ME; Gupta S
Semin Dial; 2009; 22(6):629-35. PubMed ID: 20017833
[TBL] [Abstract][Full Text] [Related]
28. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?
Meier RP; Müller YD; Morel P; Gonelle-Gispert C; Bühler LH
Stem Cell Res; 2013 Nov; 11(3):1348-64. PubMed ID: 24090934
[TBL] [Abstract][Full Text] [Related]
29. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
30. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy.
Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W
Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
32. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
[TBL] [Abstract][Full Text] [Related]
33. Rationale of mesenchymal stem cell therapy in kidney injury.
Cantaluppi V; Biancone L; Quercia A; Deregibus MC; Segoloni G; Camussi G
Am J Kidney Dis; 2013 Feb; 61(2):300-9. PubMed ID: 22938846
[TBL] [Abstract][Full Text] [Related]
34. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
Xu H; Chen C; Hu L; Hou J
Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
[TBL] [Abstract][Full Text] [Related]
35. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.
Ninichuk V; Gross O; Segerer S; Hoffmann R; Radomska E; Buchstaller A; Huss R; Akis N; Schlöndorff D; Anders HJ
Kidney Int; 2006 Jul; 70(1):121-9. PubMed ID: 16723981
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
McTaggart SJ; Atkinson K
Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic potential of intravenously administered human mesenchymal stromal cells.
Kollar K; Seifried E; Henschler R
Hamostaseologie; 2011 Nov; 31(4):269-74. PubMed ID: 22064918
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.
Luk F; de Witte SF; Bramer WM; Baan CC; Hoogduijn MJ
Expert Rev Clin Immunol; 2015 May; 11(5):617-36. PubMed ID: 25817052
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
Fan XL; Zhang Z; Ma CY; Fu QL
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
[TBL] [Abstract][Full Text] [Related]
40. Mammalian MSC from selected species: Features and applications.
Uder C; Brückner S; Winkler S; Tautenhahn HM; Christ B
Cytometry A; 2018 Jan; 93(1):32-49. PubMed ID: 28906582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
